Immune-regulating molecule may offer new treatment approach for IBD patients
Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, do not respond to…